
Telro AH 40mg/5mg/12.5mg Tablet
Marketer
Medlex Biotechnics Private Limited
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telro AH 40mg/5mg/12.5mg Tablet
Hypertensio-Trio 40mg/5mg/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, thereby mitigating the risk of future cardiovascular events like stroke and heart attack. Hypertensio-Trio may be administered with or without food; dosage is individualized based on patient response and condition, ideally at the same time daily. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. Containing a diuretic, increased urination is expected; avoid nighttime doses within four hours of bedtime. Consistent use optimizes therapeutic benefit, even during asymptomatic periods, as hypertension often presents without noticeable symptoms. Common side effects include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential dryness, thirst, and muscle weakness. Prior to commencing treatment, disclose any kidney or liver impairment to your physician. Pregnant or breastfeeding individuals should seek medical counsel. Inform your doctor of all concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure treatment efficacy.
Primary Ingredients of Telro AH 40mg/5mg/12.5mg Tablet
There is no text provided to rephrase.
Uses of Telro AH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telro AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telro AH 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telro AH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telro AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telro AH 40mg/5mg/12.5mg Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Telro AH 40mg/5mg/12.5mg Tablet works:
Each Telro AH 40mg/5mg/12.5mg tablet unites telmisartan, amlodipine, and hydrochlorothiazide—three medications working synergistically to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing blood pressure. Hydrochlorothiazide, a diuretic, facilitates fluid and electrolyte excretion via urination, further lowering pressure and enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telro AH 40mg/5mg/12.5mg tablets with alcohol is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telro AH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice before taking this medication.
Breast feedingUNSAFE
Administering Telro AH 40mg/5mg/12.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telro AH 40mg/5mg/12.5mg Tablets. These tablets may cause dizziness, headache, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telro AH 40mg/5mg/12.5mg tablets, as dose modification may be necessary. Physician consultation is advised. Telro AH 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Telro AH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Telro AH 40mg/5mg/12.5mg Tablet :
Should you forget a Telro AH 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telro AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
